Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tarsus Pharmaceuticals Inc (TARS)

Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,739,379
  • Shares Outstanding, K 42,014
  • Annual Sales, $ 182,950 K
  • Annual Income, $ -115,550 K
  • EBIT $ -109 M
  • EBITDA $ -112 M
  • 60-Month Beta 0.80
  • Price/Sales 9.54
  • Price/Cash Flow N/A
  • Price/Book 5.10

Options Overview Details

View History
  • Implied Volatility 67.48% ( -5.24%)
  • Historical Volatility 41.84%
  • IV Percentile 32%
  • IV Rank 28.36%
  • IV High 127.03% on 11/08/24
  • IV Low 43.90% on 05/27/25
  • Put/Call Vol Ratio 5.21
  • Today's Volume 1,136
  • Volume Avg (30-Day) 83
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 667
  • Open Int (30-Day) 551

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.38
  • Number of Estimates 3
  • High Estimate -0.26
  • Low Estimate -0.48
  • Prior Year -0.88
  • Growth Rate Est. (year over year) +56.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.51 +12.29%
on 07/08/25
45.48 -4.90%
on 07/18/25
+2.18 (+5.31%)
since 06/18/25
3-Month
38.51 +12.29%
on 07/08/25
53.89 -19.74%
on 05/01/25
-6.00 (-12.18%)
since 04/17/25
52-Week
20.08 +115.37%
on 08/05/24
57.28 -24.49%
on 02/05/25
+16.00 (+58.72%)
since 07/18/24

Most Recent Stories

More News

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. The company's product candidate consist TP-03 which is in clinical stage. Tarsus Pharmaceuticals Inc. is based...

See More

Key Turning Points

3rd Resistance Point 48.07
2nd Resistance Point 46.77
1st Resistance Point 45.01
Last Price 43.25
1st Support Level 41.96
2nd Support Level 40.66
3rd Support Level 38.90

See More

52-Week High 57.28
Last Price 43.25
Fibonacci 61.8% 43.07
Fibonacci 50% 38.68
Fibonacci 38.2% 34.29
52-Week Low 20.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar